MedPath

A prospective study on intra muscular injection of tramadol hydrochloride as a labour analgesic

Phase 1
Registration Number
CTRI/2020/07/026604
Lead Sponsor
Dr Amandeep kang
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Singleton live fetus with satisfactory admission CTG. In active phase of labor with cervical dilatation 4-6 cm, gestational age between 37-41weeks.Vextex presentation with no evidence of CPD.

Exclusion Criteria

History of hypersensitivity to the drug. Women with associated medical conditions like heart disease, chronic hypertension, epilepsy, respiratory and renal disease. Associated obstetrics complications APH, GDM, severe hypertension in pregnancy, multiple gestations. Previous history of Lscs, myomectomy and hysterectomy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Injection to delivery interval, decrease in labour pain by visual analogue scale. no if cases underwent cesarean nd forcep delivery forcep delivery, neonatal effects,Timepoint: From activ labour to delivery
Secondary Outcome Measures
NameTimeMethod
Side effects like nausia vomiting, drowsiness, meconium stained liquor, need for NICU admission etcTimepoint: From activ labour to post natal period
© Copyright 2025. All Rights Reserved by MedPath